Diabetes: Medications, Pathophysiology & MNT Flashcards
The islets of Langerhans secret what hormones & from what cell type?
Is the endocrine function of the pancreas. Insulin, B-cells. Glucagon, a-cells. Somatostatin, delta-cells. Pancreatic polypeptide, F or PP cells
Insulin
Produced by the beta-cells of the islets of Langerhans. Targets most cells, promotes cellular uptake, use, and storage of absorbed nutrients.
Glucagon
produced by the alpha-cells of the islets of
Langerhans. Targets most cells, Important for maintaining nutrient levels in blood during post absorptive state.
Somatostatin
Produced by the ∆ - cells of the islets of Langerhans. Targets the digestive system - inhibits digestion & absorption of nutrients; pancreatic islet cells - Inhibits secretion of all pancreatic hormones; and in the anterior pituitary gland - controls secretion of growth hormone.
Pancreatic polypeptide
Produced by the F, or PP cells of the islets of Langerhans. Targets the pancreas where is plays a possible role in reducing appetite and food intake by inhibiting postprandial pancreatic exocrine secretion.
What two hormones do the alpha cells secrete?
Glucagon and GLP-1 are secreted by the alpha-cells of the endocrine pancreas in the islets of Langerhans.
What is the function of insulin?
Directs cellular activities that favor storage of nutrients. In general, acts on hepatic, muscle, and adipose cells to allow for the uptake of glucose into the cells. Stimulated protein synthesis, glycogen synthesis, and triglyceride synthesis. Net effect is the decrease in serum BG.
GLUT-4
Is insulin dependent glucose transport molecule. Found in skeletal & cardiac muscle, and in adipocytes.
GLP-1 and GLP-2
Incretins derived from a precursor of glycogen. Stimulate the action of insulin and inhibit that of glucagon.
GADA
Glutamic acid decarboxylase autoantibodies (GADA) - Found in 70-80% of individuals with T1DM. Most sensitive marker for identifying persons at risk of developing T1DM.
Islet Cell Autoantibodies (ICA)
Found in 70-80% of individuals < 30 yo newly diagnosed with T1DM. Levels decrease the longer an individual has the disease. Is a risk factor in those who do not have T1DM.
Insulin autoantibodies (IAA)
The presence of IAA is evidence of ongoing destruction of beta-cells. Must be preformed prior to stating insulin therapy. Is an early predictive marker in children developing T1DM.
C-peptide
The peptide chain released when insulin is activated. If present, insulin is still being produced.
Initial insulin does is figured how?
0.3-0.5 units/kg is common starting point for pt. within 120% of IBW. Must be adjusted based on BG patterns.
adrenocortical hormones
steroids derived from the precursor cholesterol.